The Federal Circuit Bar Association® Patent Litigation Committee Presents: 
There’s More Than One Way to Skin a Label: The Interplay Between “Skinny Labels” and Inducement to Infringe

Panelists:

• Kathleen B. Carr, Forward Director, Fennemore Craig, P.C
• Donna Meuth, Associate General Counsel, Intellectual Property, Eisai

Summary: The generic pharmaceutical “skinny label” pendulum has swung back and forth over the years, with the extent and types of evidence considered to suffice to state a claim for induced infringement evolving in different directions on a case-by-case basis. With the upcoming U.S. Supreme Court oral argument soon to be held in Hikma v. Amarin, this timely webinar will offer insights into how the law on “skinny labeling” got to where it is, spotlight what the current state of the law is, and set the stage for the upcoming Supreme Court argument.

 View and Download the Program Flyer Here.